These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19642226)

  • 1. Synaptic scaffolding molecule binds to and regulates vasoactive intestinal polypeptide type-1 receptor in epithelial cells.
    Gee HY; Kim YW; Jo MJ; Namkung W; Kim JY; Park HW; Kim KS; Kim H; Baba A; Yang J; Kim E; Kim KH; Lee MG
    Gastroenterology; 2009 Aug; 137(2):607-17, 617.e1-4. PubMed ID: 19642226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VIP regulates CFTR membrane expression and function in Calu-3 cells by increasing its interaction with NHERF1 and P-ERM in a VPAC1- and PKCε-dependent manner.
    Alshafie W; Chappe FG; Li M; Anini Y; Chappe VM
    Am J Physiol Cell Physiol; 2014 Jul; 307(1):C107-19. PubMed ID: 24788249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and localization of VPAC1, the major receptor of vasoactive intestinal peptide along the length of the intestine.
    Jayawardena D; Guzman G; Gill RK; Alrefai WA; Onyuksel H; Dudeja PK
    Am J Physiol Gastrointest Liver Physiol; 2017 Jul; 313(1):G16-G25. PubMed ID: 28385693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of synaptic scaffolding molecule and Beta -catenin.
    Nishimura W; Yao I; Iida J; Tanaka N; Hata Y
    J Neurosci; 2002 Feb; 22(3):757-65. PubMed ID: 11826105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VPAC1 receptors regulate intestinal secretion and muscle contractility by activating cholinergic neurons in guinea pig jejunum.
    Fung C; Unterweger P; Parry LJ; Bornstein JC; Foong JP
    Am J Physiol Gastrointest Liver Physiol; 2014 May; 306(9):G748-58. PubMed ID: 24578344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial approximation between the C-terminus of VIP and the N-terminal ectodomain of the VPAC1 receptor.
    Ceraudo E; Tan YV; Couvineau A; Lacapere JJ; Laburthe M
    Ann N Y Acad Sci; 2006 Jul; 1070():180-4. PubMed ID: 16888162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VPAC1 expression is regulated by FXR agonists in the human gallbladder epithelium.
    Chignard N; Mergey M; Barbu V; Finzi L; Tiret E; Paul A; Housset C
    Hepatology; 2005 Sep; 42(3):549-57. PubMed ID: 16037943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
    Yadav M; Huang MC; Goetzl EJ
    Cell Immunol; 2011; 267(2):124-32. PubMed ID: 21295288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serine 447 in the carboxyl tail of human VPAC1 receptor is crucial for agonist-induced desensitization but not internalization of the receptor.
    Marie JC; Rouyer-Fessard C; Couvineau A; Nicole P; Devaud H; El Benna J; Laburthe M
    Mol Pharmacol; 2003 Dec; 64(6):1565-74. PubMed ID: 14645688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synaptic scaffolding molecule (S-SCAM) membrane-associated guanylate kinase with inverted organization (MAGI)-2 is associated with cell adhesion molecules at inhibitory synapses in rat hippocampal neurons.
    Sumita K; Sato Y; Iida J; Kawata A; Hamano M; Hirabayashi S; Ohno K; Peles E; Hata Y
    J Neurochem; 2007 Jan; 100(1):154-66. PubMed ID: 17059560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VIP attenuation of the severity of experimental pancreatitis is due to VPAC1 receptor-mediated inhibition of cytokine production.
    Kojima M; Ito T; Oono T; Hisano T; Igarashi H; Arita Y; Kawabe K; Coy DH; Jensen RT; Nawata H
    Pancreas; 2005 Jan; 30(1):62-70. PubMed ID: 15632701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta 1-adrenergic receptor association with the synaptic scaffolding protein membrane-associated guanylate kinase inverted-2 (MAGI-2). Differential regulation of receptor internalization by MAGI-2 and PSD-95.
    Xu J; Paquet M; Lau AG; Wood JD; Ross CA; Hall RA
    J Biol Chem; 2001 Nov; 276(44):41310-7. PubMed ID: 11526121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction.
    Ceraudo E; Hierso R; Tan YV; Murail S; Rouyer-Fessard C; Nicole P; Robert JC; Jamin N; Neumann JM; Robberecht P; Laburthe M; Couvineau A
    FASEB J; 2012 May; 26(5):2060-71. PubMed ID: 22291440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VIP enhances synaptic transmission to hippocampal CA1 pyramidal cells through activation of both VPAC1 and VPAC2 receptors.
    Cunha-Reis D; Ribeiro JA; Sebastião AM
    Brain Res; 2005 Jul; 1049(1):52-60. PubMed ID: 15935995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VPAC
    Cunha-Reis D; Ribeiro JA; de Almeida RFM; Sebastião AM
    Br J Pharmacol; 2017 Dec; 174(24):4725-4737. PubMed ID: 28945273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells.
    Delgado M; Robledo G; Rueda B; Varela N; O'Valle F; Hernandez-Cortes P; Caro M; Orozco G; Gonzalez-Rey E; Martin J
    Arthritis Rheum; 2008 Apr; 58(4):1010-9. PubMed ID: 18383379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial expression of vasoactive intestinal peptide in ulcerative colitis: down-regulation in markedly inflamed colon.
    Jönsson M; Norrgård O; Forsgren S
    Dig Dis Sci; 2012 Feb; 57(2):303-10. PubMed ID: 22143367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects.
    Summers MA; O'Dorisio MS; Cox MO; Lara-Marquez M; Goetzl EJ
    J Pharmacol Exp Ther; 2003 Aug; 306(2):638-45. PubMed ID: 12750439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of VPAC1 receptors by VIP and PACAP-27 in human bronchial epithelial cells induces CFTR-dependent chloride secretion.
    Dérand R; Montoni A; Bulteau-Pignoux L; Janet T; Moreau B; Muller JM; Becq F
    Br J Pharmacol; 2004 Feb; 141(4):698-708. PubMed ID: 14744818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.